These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20809995

  • 1. Bupropion in the treatment of depression in Parkinson's disease.
    Załuska M, Dyduch A.
    Int Psychogeriatr; 2011 Mar; 23(2):325-7. PubMed ID: 20809995
    [Abstract] [Full Text] [Related]

  • 2. [Successful treatment of depression in a Parkinson disease patient with bupropion].
    Leentjens AF, Verhey FR, Vreeling FW.
    Ned Tijdschr Geneeskd; 2000 Nov 04; 144(45):2157-9. PubMed ID: 11086491
    [Abstract] [Full Text] [Related]

  • 3. Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments.
    Raskin S, Durst R.
    Med Hypotheses; 2010 Dec 04; 75(6):544-6. PubMed ID: 20708340
    [Abstract] [Full Text] [Related]

  • 4. Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.
    Rye DB, Dihenia B, Bliwise DL.
    Depress Anxiety; 1998 Dec 04; 7(2):92-5. PubMed ID: 9614600
    [Abstract] [Full Text] [Related]

  • 5. The bupropion-related subcortical changes in a depression patient.
    Lai CH.
    Aust N Z J Psychiatry; 2015 Dec 04; 49(12):1224. PubMed ID: 25834136
    [No Abstract] [Full Text] [Related]

  • 6. Bupropion: efficacy and safety in the treatment of depression.
    Saiz Ruiz J, Gibert J, Gutiérrez Fraile M, Bobes J, Vallejo J, Iglesias C, Iriarte V.
    Actas Esp Psiquiatr; 2011 Dec 04; 39 Suppl 1():1-25. PubMed ID: 22983817
    [No Abstract] [Full Text] [Related]

  • 7. Effect of bupropion on depression symptoms in a smoking cessation clinical trial.
    Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J, Pinto A, Hawk L, Epstein LH.
    Psychol Addict Behav; 2004 Dec 04; 18(4):362-6. PubMed ID: 15631608
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
    Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DP, Buist AS, Hurt RD.
    J Gen Intern Med; 2004 Aug 04; 19(8):828-34. PubMed ID: 15242467
    [Abstract] [Full Text] [Related]

  • 9. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D.
    Lancet Neurol; 2010 Jun 04; 9(6):573-80. PubMed ID: 20452823
    [Abstract] [Full Text] [Related]

  • 10. Bupropion for treatment of interferon-induced depression.
    Malek-Ahmadi P, Ghandour E.
    Ann Pharmacother; 2004 Jun 04; 38(7-8):1202-5. PubMed ID: 15150377
    [Abstract] [Full Text] [Related]

  • 11. Paroxetine/bupropion combination treatment for refractory depression.
    Marshall RD, Liebowitz MR.
    J Clin Psychopharmacol; 1996 Feb 04; 16(1):80-1. PubMed ID: 8834426
    [No Abstract] [Full Text] [Related]

  • 12. A bupropion smoking cessation clinical trial for cancer patients.
    Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.
    Cancer Causes Control; 2010 Jun 04; 21(6):811-20. PubMed ID: 20087643
    [Abstract] [Full Text] [Related]

  • 13. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.
    Burn DJ.
    Mov Disord; 2002 May 04; 17(3):445-54. PubMed ID: 12112190
    [Abstract] [Full Text] [Related]

  • 14. Bupropion-induced hypomania in a patient with unipolar depression.
    Hussain H, Butt MA.
    Aust N Z J Psychiatry; 2008 Aug 04; 42(8):746. PubMed ID: 18622783
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of panic disorder with bupropion in a patient with Parkinson's disease.
    Gebhardt S, Röttgers H, Bäcker A, Schu U, Krieg JC.
    J Clin Pharm Ther; 2008 Oct 04; 33(5):575-7. PubMed ID: 18834374
    [Abstract] [Full Text] [Related]

  • 16. Adjunctive aripiprazole for bupropion-resistant major depression.
    Sokolski KN.
    Ann Pharmacother; 2008 Jul 04; 42(7):1124-9. PubMed ID: 18492784
    [Abstract] [Full Text] [Related]

  • 17. Drug Choices and Advancements for Managing Depression in Parkinson's Disease.
    Assogna F, Pellicano C, Savini C, Macchiusi L, Pellicano GR, Alborghetti M, Caltagirone C, Spalletta G, Pontieri FE.
    Curr Neuropharmacol; 2020 Jul 04; 18(4):277-287. PubMed ID: 31622207
    [Abstract] [Full Text] [Related]

  • 18. Bupropion-tranylcypromine combination for treatment-refractory depression.
    Pierre JM, Gitlin MJ.
    J Clin Psychiatry; 2000 Jun 04; 61(6):450-1. PubMed ID: 10901349
    [No Abstract] [Full Text] [Related]

  • 19. Bupropion sustained release: a therapeutic overview.
    Davidson JR, Connor KM.
    J Clin Psychiatry; 1998 Jun 04; 59 Suppl 4():25-31. PubMed ID: 9554318
    [Abstract] [Full Text] [Related]

  • 20. Bupropion and chronic aphthous ulceration.
    Kast RE, Altschuler EL.
    Arch Dermatol; 2005 Sep 04; 141(9):1167. PubMed ID: 16172322
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.